1202PPhase (Ph) II study of MBG453 + spartalizumab in...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1202PPhase (Ph) II study of MBG453 + spartalizumab in patients (pts) with non-small cell lung cancer (NSCLC) and melanoma pretreated with anti–PD-1/L1 therapy

Mach, N, Curigliano, G, Santoro, A, Kim, D-W, Tai, D W M, Hodi, S, Wilgenhof, S, Doi, T, Longmire, T, Sun, H, Xyrafas, A, Gutzwiller, S, Manenti, L, Lin, C-C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.028
Date:
October, 2019
File:
PDF, 89 KB
2019
Conversion to is in progress
Conversion to is failed